Carmichael S. Roberts
Co-FounderDr. Carmichael S. Roberts, Jr., Ph.D., M.B.A. is Advisor at Still Bright, Inc. Dr. Roberts serves as Board Member at AgZen Inc. He was Chairman of CubicPV Inc. until December 2024. He serves as a Director at Fleet Robotics, Inc. He co-founded Soft Robotics Inc. in 2012 and serves as its Chairman. Dr. Roberts serves as Co-Founder and Managing Partner at Material Impact Management, LLC. He serves as Partner of Breakthrough Energy Ventures Fund at Breakthrough Energy LLC. Dr. Roberts is Advisors of Bay Bridge Ventures Management LLC since joining in January 2023. He serves as a Partner, General Partner and Manager of Material Impact at North Bridge Venture Partners. He serves as Board of Directors at Mattiq. He serves as a Managing Partner Breakthrough Energy Ventures, LLC and served as a Business Lead of Investment Committee at the firm. Dr. Roberts joined North Bridge Venture Partners in October 2007. He is a Co-Founder of Nano Terra, Inc. Dr. Roberts focuses on venture and seed investments in healthcare, chemistry, materials science and materials engineering sectors. He also serves as co-founder and chairman of Diagnostics For All. Dr. Roberts financed and built several successful companies that create innovative products by applying material science, including 1366 technologies and Foro Energy. Dr. Roberts serves on the advisory boards for MIT's Deshpande Center for Innovation, Harvard's Nanoscale Science and Engineering Center and Dukes' School of Biomedical Engineering. He is Serial Entrepreneur in Chemistry and Materials. He serves as Board Observer of Nano Terra, Inc. He served as a Board Member of Foro Energy, Inc. He served as Executive Chairman of Arsenal Medical, Inc. Dr. Roberts co-founded and served as the President and Chief Executive Officer of Arsenal Biomedical, Inc. Dr. Roberts co-founded Arsenal Medical, Inc. in 2005 and served as its President and Chief Executive Officer. Dr. Roberts co-founded Surface Logix, Inc. in 1999 and served as its President, Scientific Advisor and Chief Executive Officer. He was Co-Founder of SynGlyco, Inc. He serves as a Director of Infinite Cooling Inc. He serves as Director of SOURCE Global, PBC (formerly known as Zero Mass Water, Inc.). He worked in business development at GelTex Pharmaceuticals, Inc. Dr. Roberts was responsible for new product and business development in the Sentry Products Specialty Materials Division of Dow Chemical. He started his career as a Technologist. Dr. Roberts moved into business developing applications for his research interests and subsequently to entrepreneurship and venture capitalism, exploring ways to finance those businesses. He has co-founded several other ventures, including Nano-Terra and also a Co-Founder of Lyra Therapeutics, Inc. (formerly known as 480 Biomedical, Inc.)., He served as Chairman of Sensable Technologies, Inc. He served as Vice Chairman of Nano Terra, Inc. He served as a Director of SynGlyco, Inc.(Ancora Pharmaceuticals, Inc.). He served as a Lead Director of Arsenal Medical, Inc. until December 21, 2016. Dr. Roberts served on the board of directors of the Duke Alumni Association from 2007 to 2013. He served as the Chairman at 480 Biomedical until December 22, 2017. He served as a Trustee of the Berklee College of Music. In 1999, Dr. Roberts was named one of the world's top 100 young entrepreneurs by MIT's Technology Review. He has successful career as an entrepreneur-investor in materials, blending a unique business model of licensing university technology and commercializing it through targeted partnerships with Fortune 500 companies. He is a long-time commercial and scientific collaborator at Harvard University Dr. Roberts received a Ph.D. between 1990 to 1995 and a B.S. Degree in between 1986 to 1990 in Organic Chemistry from Duke University and completed his Postdoctoral National Science Foundation fellowship at Harvard University between 1995 to 1996. Dr. Roberts received an M.B.A. Degree from the MIT Sloan School of Management between 1998 to 2000.
Positions
- Company NameLyra Therapeutics, Inc.Stock CodeLYRAPositionCo-FounderColleagues
- CAC. Ann MerrifieldIndependent Director
- VBVineeta BelangerSenior Vice President of Clinical Affairs
- ANAllison NanceSenior Vice President of Regulatory Affairs
- ERElazer R. EdelmanVP of Finance & Risk
- WBW. Bradford SmithIndependent Director
- JRJames R. TobinLead Independent Director
- NLNancy L. SnydermanIndependent Director
